Ayala Pharmaceuticals Inc (ADXS)

[cdiddy01]

I'm wondering, without a meaningful HOT deal, how will this not continue to melt until NEO data? I personally don't think they can make it to NEO data without additional funding, but tough to say. When NEO data drops, all bets are off, good or bad.

A HOT deal without reasonable money will also not do much, IMO. While a deal where costs are unloaded is a positive, expenses will only continue with the development of the additional 3-4 constructs they have planned to accelerate into clinical. I still wonder if they try and piecemeal HOT, or just sell the whole thing ala NEO at this point. If they're waiting for NEO data before licensing HOT, then why not just shelve the development and get there first?

Bottom line, I have no idea where the bottom is for this thing. They refuse to show any hand when it comes to HOT. The "in talks" is the same as in "late stage" talks with AXAL, we've seen what that has meant for investors.